What the business is, and whether it's a good one at a fair price.
Operates as a single-segment specialty chemicals business, with FY26 revenue from operations of Rs 218.60 cr and total assets of Rs 659.94 cr. In Q1 FY27, revenue from operations reached Rs 83.55 cr, up 49.5% from Rs 55.88 cr in the same quarter a year earlier, while profit after tax rose to Rs 15.10 cr from Rs 12.03 cr. The cost structure is dominated by other operating expenses at 33.1% of revenue and materials at 26.2%, with employee costs at 18.2% and depreciation at 9.8%. Capital expenditure absorbs a notably high 40.3% of revenue, signalling an asset-heavy expansion mode relative to current turnover. The company sits within the Alembic group, with promoter/promoter-group entities including Alembic Pharmaceuticals Ltd and Shreno entities. An earlier share sub-division and 3-for-1 bonus issue were completed in October 2025, and a final dividend for FY26 was declared at the 53rd AGM, payable on or from 3 August 2026.
Measured from the filed financials, judged against its Specialty Chemicals peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from PAUSHAK LIMITED's filed financials and exchange disclosures
PAUSHAK LIMITED is a Chemicals & Petrochemicals company listed on NSE and BSE, trading under the symbol PAUSHAKLTD.
Yes. Over the trailing twelve months PAUSHAK LIMITED reported a net profit of ₹42 Cr on revenue of ₹246 Cr.
Yes. The dividend yield is 0.34% at the current price. It paid out 15% of its profit as dividend in FY26.
No. Debt stands at 0.16× equity, and it carries net debt of ₹77 Cr. That is lower than 52% of its 101 Specialty Chemicals peers.
On trailing P/E, PAUSHAK LIMITED ranks 33 of 103 in Specialty Chemicals — cheaper than 69% of them, against an industry median of 23.4×. This is a position, not a valuation judgement.
On a typical session PAUSHAK LIMITED moves 1.91% — that is the median absolute close-to-close move across its last 193 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by PAUSHAK LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
